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 VITAMIN A COMPOUNDS IN  
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Jenna M. Paseka, MS, RD, LMNT 
University of Nebraska, 2016 
Advisor: Corrine K Hanson, PhD, RD, LMNT 
OBJECTIVE:  Little is known about the vitamin A status in mothers and infants at birth in the 
United States.  The main objective of this study is to determine associations between maternal 
and infant serum retinol, provitamin A carotenoids, and non-provitamin A carotenoids.  The 
secondary aim is to explore the relationship between maternal intake and maternal and infant 
serum levels of vitamin A compounds. 
METHODS: This was a prospective cohort of 34 mothers and their infants admitted to the 
neonatal intensive care unit (NICU).  Maternal and cord blood samples were collected at delivery.  
Serum retinol, lutein + zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, and β-carotene 
concentrations were measured using high-performance liquid chromatography (HPLC).  Food 
frequency questionnaires (FFQs) were obtained to assess maternal dietary vitamin A intake.  
Descriptive statistics and Spearman correlation coefficients were calculated.  P-value <0.05 was 
considered statistically significant. 
RESULTS: The mean birth weight was 2738.0 ± 835.7 gm and mean gestational age was 36.7 ± 
3.4 weeks.  Vitamin A deficiency (VAD) was present in 71.9% of infants and 12.9% of mothers.  
Significant positive correlations were found between maternal-infant serum lutein + zeaxanthin 
(r=0.50, p=0.004), β-cryptoxanthin (r=0.83, p=<0.001), trans-lycopene (r=0.68, p=<0.001), cis-
lycopene (r=0.52, p=0.003), total lycopene (r=0.63, p=<0.001), α-carotene (r=0.67, p=<0.001), 
trans-β-carotene (r=0.74, p=<0.001), cis-β-carotene (r=0.44, p=0.013), total-β-carotene (r=0.71, 
p=<0.001), and retinol (r=0.42, p=0.018). 
 CONCLUSION: VAD is a significant health problem in infants in the NICU.  Infant vitamin A 
status is correlated with maternal levels and may be influenced by maternal dietary intake 
throughout pregnancy. 
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CHAPTER 1: INTRODUCTION 
Vitamin A is a key micronutrient for growth and development, making it especially 
important for developing fetuses and infants.  Vitamin A plays an important role in lung and 
vision development, immune function, and overall cellular growth.1-4  Various provitamin A 
carotenoids are thought to have specific characteristics including antioxidant properties, 
immunoenhancement, and decreasing the risk of disorders that impact vision, aside from retinol 
alone.5,6  Low dietary vitamin A intake is most strongly associated with health consequences 
during infancy, childhood, pregnancy, and lactation due to the high nutritional demands at these 
times of increased growth and development.7  
Retinol levels of infants have been well-documented and have been considered the 
standard serum measurement that determines vitamin A adequacy or deficiency.  The World 
Health Organization (WHO) estimates there are up to 122 countries with vitamin A deficiency 
(VAD), affecting 190 million preschool-age children.  In addition to children, it is estimated that 
19.1 million pregnant women are deficient, thus putting their infants at risk of deficiency at birth.8  
Worldwide, the focus has been to identify and target poorer countries.  VAD is commonly 
identified in the United States among the malnourished or chronically sick populations, but has 
often been overlooked in pregnant women and infants.  The presence of VAD within the 
population of the United States has not been surveyed or identified by WHO.  Because those 
living in the United States have higher gross incomes and better access to food, it is assumed that 
VAD is not a public health concern.7  This gap in knowledge warrants an evaluation of the 
vitamin A status in pregnant women and infants in the United States. 
In addition, little is known about the way carotenoids influence the outcomes of pregnant 
women and their infants, recommendations for adequate intake, and normal serum levels.  The 
main objective of this study is to evaluate and determine associations between maternal and infant 
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serum retinol, lutein + zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, and β-carotene levels at 
birth.  The secondary aim is to explore the relationship between maternal intake and maternal and 
infant serum levels of vitamin A compounds. 
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CHAPTER 2: BACKGROUND & REVIEW OF LITERATURE 
OVERVIEW OF VITAMIN A 
Structure, Metabolism and Storage:   
Vitamin A is a fat soluble-vitamin that can be obtained from the diet in two forms, 
preformed vitamin A or provitamin A carotenoids.  Preformed vitamin A includes retinol and its 
esterified form, retinyl ester.  These can be found in animal sources such as dairy products, fish, 
meat, and eggs and comprise ≥70% of the daily vitamin A intake in the United States.9  
Provitamin A carotenoids are precursors for retinol and include β-carotene, α-carotene, and β-
cryptoxanthin.  These must be obtained from the diet and are found in fruits, vegetables, and 
oils.10  Provitamin A carotenoids provide ≤30% of the daily vitamin A intake in the United 
States.9  Another group of carotenoids, non-provitamin A carotenoids, includes lutein, zeaxanthin, 
and lycopene.  This subset of carotenoids, though, cannot be converted into retinol.7,10,11  In 
general, the term “vitamin A” is defined as the all-trans-retinol form.12  
Retinol, retinal, and retinoic acid are the three active forms and retinyl ester is the storage 
form of vitamin A.  Absorption of preformed vitamin A occurs in the small intestine after retinyl 
esters are compiled with triglycerides in micelles.10  Products of fat digestion and bile secretions 
are essential in this process.13  If dietary fat intake is low, retinol and carotenoid absorption is 
markedly reduced.13,14  Dietary retinoids can also be converted into retinoic acid in the intestine.  
Efficiency of absorption of preformed vitamin A is 70-90%.  As intake of these forms increases, 
the absorbability remains high.  Carotenoids are absorbed similarly to preformed vitamin A in the 
intestinal lumen, but efficiency of absorption decreases as the amount of dietary carotenoids 
increases.  It has been reported that 9-22% of β-carotene ingested is absorbed.  Once the vitamin 
A forms are absorbed, they are transported to the liver via chylomicron remnants and mainly 
stored as retinyl esters.10  The body stores approximately 80-90% of vitamin A in the liver as 
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retinyl ester.12  Retinyl esters can be hydrolyzed into retinol as needed and transported to other 
tissues when bound to retinol-binding protein (RBP).  Carotenoids are integrated into very low 
density lipoproteins (VLDL) to be sent throughout the bloodstream to other tissues.10  Figure 1 
shows the metabolic pathways and conversion capabilities of different vitamin A forms.   
 
Figure 1: Vitamin A Metabolism  
 
  
  
Functions:   
Vitamin A serves many important functions in the body and is crucial during periods of 
growth and development.  It is involved in regulating and promoting cell growth and 
differentiation,3 maintaining the integrity of respiratory epithelial cells,4 visual development, 
reproductive functions, and improving the immune system.  Vitamin A is especially important in 
fetal lung development and surfactant synthesis.  In regards to vision, it is an important part of the 
 
 
Figure 1: Vitamin A Metabolism.  Generalized pathways from intake of provitamin A carotenoids, 
retinol, or retinyl esters for use in the body, storage, or elimination.12 
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photosensitive visual pigment complex in the retina.1  It is required for differentiation of the 
cornea, conjunctival membranes, and photoreceptor rod and cone cells.10   
According to the Institute of Medicine (IOM), the only known function of provitamin 
carotenoids is vitamin A activity.  Carotenoids are thought to have “antioxidant activity, 
immunoenhancement, inhibition of mutagenesis and transformation, inhibition of premalignant 
lesions, quenching of nonphotochemical fluorescence, and activity as a pigment in primate 
macula.”15  β-carotene, specifically, has been documented to have antioxidant properties by 
trapping free radicals and reducing oxidative stress or damage.1,2,5   
The non-provitamin A carotenoids lutein, zeaxanthin, and lycopene have been shown to 
function in the body, despite not being converted into retinol.  It is thought that lutein and 
zeaxanthin influence the maturation of cells in the macular region of the retina16 and protect 
against stress and oxidation in the retinal pigment epithelium.6  This region is responsible for 
developing central visual acuity.  There also appears to be a link between lutein and zeaxanthin 
and improved cognitive function.  Vishwanathan et al. determined that the mean concentration of 
lutein was significantly greater than the other carotenoids in brain tissue samples of infants who 
died within the first 18 months of life (p=<0.05).  Preterm infants also had significantly lower 
concentrations of lutein and zeaxanthin compared to term infants in most of the brain regions 
(p=<0.05).  These findings in addition to previous research help support the role lutein and 
zeaxanthin play in visual and cognitive development.16  Little is known about the function of 
lycopene in pregnant women and infants.  It is thought that lycopene can act as an antioxidant,11 
impact immune development, and protect against inflammatory diseases.6  In general, lycopene 
has been associated with benefits in cardiovascular disease, neurological disorders, and cancer.17 
Oxidative stress that commonly occurs in infants in the neonatal intensive care unit 
(NICU) is associated with many conditions such as bronchopulmonary dysplasia (BPD), 
respiratory distress, retinopathy of prematurity (ROP), and necrotizing enterocolitis (NEC), as 
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well as an increased risk of infection.18  Ensuring adequate vitamin A status at birth, particularly 
specific vitamin A forms found to decrease oxidative stress, may provide protective benefits to 
infants at an increased risk of developing these conditions or positively impact an infant’s 
recovery from these complications. 
Dietary Reference Intakes:   
The Dietary Reference Intakes (DRIs) established by the IOM are available for vitamin A for 
different age categories ranging from infants to older adults.  The DRIs are reported in retinol 
activity equivalents (RAE).  Retinol and provitamin A carotenoids are converted into common 
units of RAE to accommodate the different bioactivities.  Lutein, zeaxanthin, and lycopene, on 
the other hand, cannot be converted into RAE, thus they do not possess vitamin A activity.  
Conversion rates are used to determine RAE in food and supplements as nutrition facts labels and 
supplement labels currently report vitamin A in international units (IUs).7  Knowing the source is 
necessary to determine appropriate conversions to RAE.  The following are conversion rates 
between IUs and RAE: 
 1 IU retinol = 0.3 µg RAE 
 1 IU β-carotene from dietary supplements = 0.15 µg RAE 
 1 IU β-carotene from food = 0.05 µg RAE 
 1 IU α-carotene or β-cryptoxanthin = 0.025 µg RAE7 
Vitamin A intake may also be measured in µg which can also be converted into RAE.  The 
following are conversion rates between an RAE and µg for specific vitamin A forms: 
 1 µg RAE = 1 µg retinol 
 1 µg RAE = 2 µg β-carotene in oil 
 1 µg RAE = 12 µg β-carotene in mixed foods 
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 1 µg RAE = 24 µg other provitamin A carotenoids in mixed foods19  
The DRIs for vitamin A are displayed in Table 1.  In adult females 19 years and older, the 
Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA) for 
vitamin A is 500 µg RAE/day and 700 µg RAE/day, respectively.  In pregnant women, vitamin A 
needs increase to 550 µg RAE/day for the EAR and 770 µg RAE/day for the RDA.  Increased 
needs during pregnancy take into account accumulation of vitamin A in the liver of the fetus 
during gestation.  The Tolerable Upper Intake Level (UL) for non-pregnant and pregnant women 
is 3000 µg/day of preformed vitamin A.10 
The Adequate Intake (AI) for vitamin A in infants 0-6 months is 400 µg RAE/day.  The 
AI for infants is established from the mean human milk intake in healthy breastfed infants, 
assuming an average total human milk intake of 0.78 L/day.  The average concentration of 
vitamin A in human milk is 1.70 mmol/L.  The UL for infants is defined at a level of 600 µg 
RAE/day of preformed vitamin A.10 
 
Table 1: Dietary Reference Intakes for Infants and Women  
   
Age Group EAR RDA AI UL 
Infants 0-6 months   400 600 
Women ≥19 years 500 700  3000 
Pregnant Women  ≥19 years 550 770  3000 
Lactation ≥19 years 900 1300   3000 
 
The Dietary Reference Intakes for vitamin A as reported by the Institute of Medicine.   
Values are reported in µg RAE/day of vitamin A.10 
 
 
There are currently no established DRIs for carotenoids.  The IOM concluded in their 
most recent report in 2000 that existing evidence was insufficient to establish recommended 
intake values.  Current research cannot exclude the possibility of other substances found in 
carotenoid-rich food being the parts that are contributing to health benefits.  The IOM, though, 
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does support recommendations for increasing consumption of carotenoid-rich fruits and 
vegetables.15   
In a report by Strobel et al., β-carotene needs are increased during pregnancy and the 
breastfeeding period.  It was recommended that β-carotene intake should be one third higher 
during pregnancy and 0.7 mg/day higher during lactation than that for non-pregnant or non-
breastfeeding women.14 
 
 
VITAMIN A DEFICIENCY 
VAD is associated with a high risk of xerophthalmia and can cause childhood 
blindness.20  Immunity can also be compromised if deficient, especially in infants, due to the 
reduction in the function of neutrophils, macrophages, and natural killer cells as well as 
interference with the regeneration of damaged mucosal barriers.9  VAD contributes to morbidity 
and mortality from infections.8 
VAD can be diagnosed by a clinical presentation of xerophthalmia and may be the only 
assessment method if serum retinol concentrations cannot be obtained.  Xerophthalmia 
encompasses night blindness, conjunctival xerosis, Bitot’s spots, corneal xerosis, corneal 
ulceration and necrosis, corneal scarring, and xerophthalmic fundus.8 
Although an individual may not be showing clinical signs of deficiency such as 
xerophthalmia and night blindness, subclinical VAD can also be present.  This can contribute to 
increased susceptibility to infections, reduced physical growth, and decreased survival from 
serious illness.  Populations at risk of subclinical VAD may include those living at or below the 
poverty level, those with inadequate health care and immunizations, those with other nutritional 
deficiencies, recent immigrants or refugees from countries with a high incidence of deficiency, 
and those with ineffective fat digestion.21 
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Assessing liver reserves is considered the gold standard to measure adequacy or 
deficiency of vitamin A, but this method is not feasible in humans.22  Plasma retinol levels, 
though, can be indicative of vitamin A status and liver reserves.  If hepatic vitamin A reserves are 
adequate, there will be little change in the concentration of retinol in the blood.  The hepatic 
stores must be depleted before a decline in plasma levels is detected.  If serum retinol levels are 
<1.05 µmol/L, storage levels are likely reduced.12   
In 1980, a serum retinol level <0.35 µmol/L was used by WHO to define VAD among 
children younger than six years of age and was associated with an increased prevalence of clinical 
signs of deficiency.  The cut-off level was then raised in 1996 after consensus by members of 
WHO.  It was believed that using <0.35 µmol/L was too low to identify individuals at risk for 
subclinical consequences of deficiency, but had not yet displayed clinical signs of severe 
deficiency.  Serum retinol levels <0.70 µmol/L are now considered deficient, while levels <0.35 
µmol/L are indicative of a severe deficiency where liver stores have been depleted.23   
A serum retinol level >1.05 µmol/L has been proposed by WHO as an adequate 
concentration for vitamin A status among pregnant and lactating women.8  This cut-off value has 
been utilized in various research studies to determine adequate vs. inadequate vitamin A levels in 
mothers and infants.20,24-26  Radhika et al. discovered that spontaneous preterm delivery and 
anemia were significantly associated with serum retinol <20 µg/dL (<0.70 µmol/L) and 
recommended maintaining levels >20 µg/dL (>0.70 µmol/L) at a minimum.27 
An additional test that has been used to assess vitamin A status in infants is the relative 
dose-response (RDR) test.  Weinman et al. used it to assess vitamin A status of 124 newborn 
preterm infants <37 weeks gestational age.  To perform the RDR test, blood samples in newborn 
infants were obtained before and 5 hours after an intramuscular injection of 5000 IU of vitamin 
A.  It is expected that this amount would increase the serum retinol levels by 10-20% if hepatic 
reserves are normal.  A positive RDR test was defined as retinol levels increasing >20% at >/= 5 
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hours after administration, indicative of deficient liver vitamin A stores.  When deficiency was 
defined as <20 µg/dL (0.70 µmol/L), the test underestimated the number of deficient 
infants.  Using <30 µg/dL (1.05 µmol/L) as a deficient level, the test overestimated 
VAD.  Weinman et al. concluded that <25 µg/dL (0.87 µmol/L) was more appropriate for 
defining VAD.28 
Although clear worldwide deficiency standards are lacking for infants and pregnant 
women, recommendations by WHO are generally recognized internationally.  Overall, 
populations are defined as severely deficient (<0.35 µmol/L), deficient (0.35-0.70 µmol/L), low 
(0.70-1.05 µmol/L), or adequate (>1.05 µmol/L) based upon their serum retinol levels.8,25,29 
The level of public health significance of VAD in a population has been established by 
WHO.  Deficiency is considered mild if ≥2-<10%, moderate if ≥10-<20%, or severe if ≥20% of 
children 6-71 months of age have serum retinol concentrations 0.70 µmol/L or lower.23  Figures 
2-3 demonstrate the public health significance of VAD in preschool-age children and pregnant 
women in the world when evaluating serum retinol concentrations.  A clinical presentation of 
night blindness can also be used to define the level of public health significance of VAD.  A mild, 
moderate, and severe deficiency affects >0-<1%, ≥1-<5%, and ≥5% of children 24-71 months of 
age, respectively, if night blindness is present.8 
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Figure 2.1: Vitamin A Deficiency in Preschool-age Children  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Estimated Vitamin A Deficiency in Preschool-age Children  
 
Figure 2.1: Vitamin A Deficiency in Preschool-age Children.  Public health significance of global 
vitamin A deficiency in preschool-age children based upon the World Health Organization’s survey 
data of retinol levels <0.70 µmol/L from 1995-2005.8 
 
Public health significance of global vitamin A deficiency in preschool-age children based upon the 
World Health Organization’s survey data of retinol levels <0.70 µmol/L from 1995-2005.8 
 
 
Figure 2.2: Estimated Vitamin A Deficiency in Preschool-age Children.  Public health significance 
of global vitamin A deficiency in preschool-age children based upon the World Health Organization’s 
survey data and regression-based estimates of retinol levels <0.70 µmol/L from 1995-2005.8 
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Figure 3.1: Vitamin A Deficiency in Pregnant Women   
 
 
Figure 3.2: Estimated Vitamin A Deficiency in Pregnant Women   
 
Figure 3.1: Vitamin A Deficiency in Pregnant Women.  Public health significance of global vitamin 
A deficiency in pregnant women based upon the World Health Organization’s survey data of retinol 
levels <0.70 µmol/L from 1995-2005.8 
 
 
 
Figure 3.2: Estimated Vitamin A Deficiency in Pregnant Women.  Public health significance of 
global vitamin A deficiency in pregnant women based upon the World Health Organization’s survey 
data and regression-based estimates of retinol levels <0.70 µmol/L from 1995-2005.8 
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Efforts have been made in poorer countries to increase vitamin A intake through diet, 
supplementation, and fortification.  In 1995, WHO estimated that deficiency was a public health 
significance in 60 countries and likely a problem in an additional 13 countries.  Newer estimates 
reflecting the time period of 1995-2005 indicate that 45 countries have VAD based on the 
prevalence of night blindness and 122 countries based on serum retinol concentrations <0.70 
µmol/L in preschool children.8   
In a survey conducted between 1995 and 2005 in countries with a 2005 gross domestic 
product (GDP) <$15,000, 15.3% of pregnant women (95% CI: 7.4-23.2) had serum retinol levels 
below 0.70 µmol/L.  This accounts for 19.1 million pregnant women.  Preschool-age children 
were also evaluated with 33.3% (95% CI: 31.1-35.4) deficient which translated into 190 million 
children affected.  When evaluating the six WHO regions, the prevalence of deficiency in 
pregnant women was highest in the Western Pacific region (21.5%; 4.90 million), South-East 
Asia (17.3%; 6.69 million), the Eastern Mediterranean region (16.1%; 2.42 million), Africa 
(13.5%; 4.18 million), Europe (11.6%; 0.72 million), and the Americas (2.0%; 0.23 million).  In 
preschool-age children, the prevalence was highest in South-East Asia (49.9%; 91.5 million), 
Africa (44.4%; 56.4 million), the Eastern Mediterranean region (20.4%; 13.2 million), Europe 
(19.7%; 5.81 million), the Americas (15.6%; 8.68 million), and the Western Pacific region 
(12.9%; 14.3 million).8  VAD contributes to 1.2-3.0 million deaths in children, and leads to the 
development of xerophthalmia in 4.4 million children and 6.2 million mothers each year.30 
The main underlying cause of deficiency is a diet insufficient in vitamin A.  The risk of 
health consequences is greatly increased if there is low vitamin A intake during periods of growth 
and development such as pregnancy, infancy, and childhood.8  VAD in infants can develop when 
their mothers are deficient during pregnancy or during lactation if infants are breastfed, when 
infants receive diets offering very few sources of vitamin A, and/or when infants suffer from 
ongoing illnesses contributing to malnutrition, malabsorption, and increased catabolism.31  
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MATERNAL AND CORD BLOOD VITAMIN A LEVELS 
Maternal-fetal Transfer: 
The growing embryo and fetus require circulating maternal vitamin A for developmental 
needs since there is no de novo synthesis of vitamin A.  This transfer occurs through the placenta, 
the maternal-fetal barrier.  The placenta is thought to be the storage site for vitamin A until the 
embryonic liver is functional.32  Fetal liver stores then tend to increase with increasing gestational 
age, typically doubling between the 25th and 37th week gestation.18  Building fetal liver stores 
is still strongly dependent on the vitamin A status of the mother.14  The placenta also serves to 
release retinol to the fetus when maternal dietary intake is low or to store extra retinol to prevent a 
toxic excess from maternal retinoids.  The process of placental transfer is not clear.  Possible 
mechanisms include direct transfer of the retinol-RBP complex, transfer of free retinol, or cellular 
uptake of retinol by a specific receptor Stra6.32 
β-carotene from maternal blood may also reach the fetus through placental uptake of β-
carotene-containing chylomicrons, VLDL, and low density lipoproteins (LDL).  Spiegler et al. 
hypothesized that “maternally circulating β-carotene can be delivered to the developing tissues 
and there cleaved to generate retinoic acid in situ.”32  This may be beneficial in times of 
insufficient dietary intake of other vitamin A compounds.   
Relationship of Vitamin A Status in Mothers and Infants: 
Various studies have evaluated retinol concentrations in mothers and infants at birth.  It 
has been reported that maternal and cord blood retinol and carotenoid concentrations are directly 
correlated14 and are significantly higher in mothers than in cord blood levels (p<0.0001).33  β-
carotene levels, specifically, in mothers have been found to be significantly higher and correlate 
with cord blood levels.32  Limited research is available describing the relationship of the other 
provitamin A and non-provitamin A carotenoids between mothers and infants. 
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Saunders et al. described retinol blood levels in 217 mothers and 222 infants born at a 
mean gestational age of 39 ± 1.7 weeks in Rio de Janeiro, Brazil.  VAD was defined as serum 
levels <1.05 µmol/L in both mothers and infants.  The mean postpartum level in mothers was 
1.70 ± 0.86 µmol/L with 24.4% of the mothers being vitamin A deficient.  The mean 
concentration in umbilical cord blood was 1.29 ± 0.75 µmol/L, and the prevalence of VAD was 
45.5%.  Placental transfer of vitamin A, or the ratio of infant to maternal serum concentration, 
was 75.9%.24  Another study in Recife, Brazil of 65 term normal birth weight infants (>2500 
grams) determined the mean serum retinol levels at birth to be 1.46 ± 0.63 µmol/L in mothers and 
1.13 ± 0.60 µmol/L in infants.  Placental transfer was similar to the previous study in Rio de 
Janeiro, Brazil at 77.4%.  Although the mean retinol concentrations were considered normal in 
both groups, 23.1% of infants and 23% of mothers were considered deficient in the sample when 
VAD was defined as <0.70 µmol/L in infants and <1.05 µmol/L in mothers.  The serum retinol 
concentrations of infants was also positively correlated with maternal serum retinol 
concentrations (r=0.27, p=0.04).25 
Comparisons have been made between serum retinol levels in mothers after delivery and 
non-pregnant women from the same community in South Africa as well as newborns with a mean 
gestational age of 38.9 ± 1.9 weeks and preschool children from the same community.  The mean 
serum retinol level for mothers was 1.03 ± 0.40 µmol/L, while non-pregnant women had a mean 
level of 1.93 ± 0.50 µmol/L.  Newborns and preschool children had mean retinol levels of 0.73 ± 
0.24 µmol/L and 1.10 ± 0.27 µmol/L, respectively.  There were 49.3% of infants and 21.4% of 
mothers with retinol levels <0.70 µmol/L.  A significant positive correlation was found between 
serum retinol concentrations in the mothers and newborns (r=0.227, p=0.001).34 
In healthy mothers and infants with a mean gestational age of 39.5 ± 1.6 weeks in China, 
mean maternal vitamin A concentration was 1.13 ± 0.371 µmol/L and cord blood levels were 
0.69 ± 0.162 µmol/L.  Of the mothers, 16.8% were considered to be deficient with levels below 
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0.70 µmol/L as well as 36.4% had low levels ranging between 0.70 and 1.05 µmol/L.  Of the 
infants, 41.3% were deficient and 56.6% had a low vitamin A status.  The mean placental transfer 
of vitamin A was 78.3 ± 35.2%.20 
Infant birth weight has thought to also influence vitamin A levels in infants.  Agarwal et 
al. discovered mean serum retinol levels were 13.3 ± 8.2 µg/dL (0.47 ± 0.29 µmol/L) in 146 low 
birth weight infants (<2500 grams) and 14.0 ± 6.2 µg/dL (0.49 ± 0.22 µmol/L) in 79 normal birth 
weight infants (≥2500 grams) in India (p=0.51).  Deficiency in infants was defined as retinol 
levels <10 µg/dL (<0.35 µmol/L).  Of the low birth weight and normal birth weight infants, 
41.1% and 24.1%, respectively, were vitamin A deficient.  Mean maternal levels were 39.0 ± 15.5 
µg/dL (1.36 ± 0.54 µmol/L) for mothers of low birth weight infants and 38.1 ± 16.3 µg/dL (1.33 
± 0.57 µmol/L) for mothers of normal birth weight infants (p=0.69).  VAD defined as <20 µg/dL 
(0.70 µmol/L) in mothers was present in 11.5% of low birth weight and 9.0% of normal birth 
weight infants’ mothers.  Placental transfer was 34.1% for low birth weight infants and 36.7% in 
normal birth weight infants.35 
Vitamin A Status – Data Exclusive to Infants Only: 
In a study evaluating 350 infants weighing <1250 grams at birth at the University of 
Washington who had a serum retinol concentration measured in the first 28 days of life, 55% had 
vitamin A levels <0.35 µmol/L.  Mean retinol concentrations were not reported.4  Kositamongkol 
et al. also evaluated 31 very low birth weight infants (<1500 grams) at birth in Thailand.  The 
median retinol level at birth was 15.5 µg/dL (IQR 10.5-24.9 µg/dL) (0.54 µmol/L (IQR 0.37-0.87 
µmol/L)).  The deficiency rate in this group was 67.7% when VAD was defined as retinol levels 
<20 µg/dL (<0.70 µmol/L).  Severe VAD with concentrations <10 µg/dL (<0.35 µmol/L) was 
present in 19% of the infants.3 
In a study of 56 infants <33 weeks gestational age in Finland, 22 infants were found to 
have low vitamin A levels (<1.05 µmol/L) in umbilical cord samples with two of those subjects 
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being deficient (<0.70 µmol/L).  Tammela et al. also compared serum levels of infants whose 
mothers either received or did not receive multivitamin supplementation during pregnancy.  The 
serum levels of infants of mothers who did not use supplements were not significantly different 
from those that did with serum levels of 1.19 µmol/L and 1.29 µmol/L, respectively (p=0.273).26 
Vitamin A Status – Data Exclusive to Mothers Only: 
Throughout pregnancy, serum vitamin A levels in mothers tend to decrease as plasma 
volume expands in the later trimesters.  Normal maternal serum levels were found to be 25.6 ± 
7.6 µg/dL (0.90 ± 0.27 µmol/L) in the first trimester, 24.0 ± 7.8 µg/dL (0.84 ± 0.27 µmol/L) in 
the second trimester, 24.6 ± 9.3 µg/dL (0.86 ± 0.33 µmol/L) in the third trimester, and 35.3 ± 8.9 
µg/dL (1.23 ± 0.31 µmol/L) postpartum.36  The Third National Health and Nutrition Examination 
Survey (NHANES III) collected from 1988-1994 reported mean serum retinol levels in pregnant 
women to be 1.47 µmol/L.10  In a study by Radhika et al., 736 women in their third trimester of 
pregnancy in India were enrolled to evaluate VAD.  The mean serum retinol level of mothers was 
27.1 ± 11.4 µg/dL (0.95 ± 0.40 µmol/L).  Thirty-five percent of mothers had an adequate vitamin 
A status when defined as serum retinol levels ≥30 µg/dL (≥1.05 µmol/L).  A small portion of the 
mothers (3.5%) were considered severely deficient with levels <10 µg/dL (<0.35 µmol/L).  It was 
recommended that mothers obtain serum retinol levels >20 µg/L (>0.70 µmol/L) during 
pregnancy to avoid increased complications including preterm delivery, moderate to severe 
anemia, and pregnancy-induced hypertension.27 
Relationship of Carotenoids in Mothers and Infants: 
Although many research studies have evaluated serum retinol concentration levels, 
information on the serum levels of carotenoids is limited.  A study in Germany evaluated 151 
maternal and 200 cord blood samples to assess the different vitamin A forms in maternal and cord 
blood at birth.  Infants had a mean gestational age of 39.1 ± 1.5 weeks, 10% of the infants were 
born preterm (<37 weeks), and 8.5% had a low birth weight (<2500 grams).  The mean maternal 
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and cord retinol levels, respectively, were 1.15 µmol/L (95% CI: 1.09, 1.21) and 0.90 µmol/L 
(95% CI: 0.85, 0.95) (r=0.099, p=0.228), lutein levels were 0.528 µmol/L (95% CI: 0.494, 0.563) 
and 0.021 µmol/L (95% CI: 0.014, 0.030) (r=0.368, p=<0.001), zeaxanthin levels were 0.111 ± 
0.056 µmol/L and undetectable, β-cryptoxanthin levels were 0.399 ± 0.259 µmol/L and 
undetectable, lycopene levels were 1.08 ± 0.429 µmol/L and undetectable, α-carotene levels were 
0.323 µmol/L (95% CI: 0.277, 0.376) and 0.004 µmol/L (95% CI: 0.003, 0.005) (r=0.668, 
p=<0.001), and β-carotene levels were 0.755 µmol/L (95% CI: 0.675, 0.845) and 0.013 µmol/L 
(95% CI: 0.010, 0.017) (r=0.832, p=<0.001).  Comparisons were also made between preterm and 
term infants.  The only statistically significant finding between preterm and term infants was 
retinol concentrations, 0.70 vs. 0.90 µmol/L (p<0.001) for preterm and term infants, respectively.  
Lutein (0.01 vs 0.03 µmol/L, p=0.268), α-carotene (0.00 vs. 0.00 µmol/L, p=0.963), and β-
carotene (0.02 vs. 0.01 µmol/L, p=0.531) were not significantly different in the preterm and term 
infants, respectively.  Zeaxanthin, β-cryptoxanthin, and lycopene were all below the limit of 
detection in the cord blood samples.  Maternal lutein (r=0.368, p=<0.001), α-carotene (r=0.668, 
p=<0001), and β-carotene (r=0.832, p=<0.001) levels were positively correlated with cord blood 
samples.18   
A study in Ireland assessed retinol and carotenoid concentrations in 66 samples from 
mothers and 40 cord blood samples from infants with a mean birth weight of 3439 ± 486 grams.  
The mean levels in mothers and cord blood, respectively, were 1.88 ± 0.4 µmol/L and 1.01 ± 0.3 
µmol/L of retinol, 0.46 ± 0.2 µmol/L and 0.13 ± 0.1 µmol/L of lutein + zeaxanthin (n=38 
detectable cord blood samples), 0.14 ± 0.1 µmol/L and 0.04 ± 0.03 µmol/L of β-cryptoxanthin, 
0.40 ± 0.2 µmol/L and 0.04 ± 0.03 µmol/L of lycopene (n=12 detectable cord blood samples), 
0.23 ± 0.1 µmol/L and 0.04 ± 0.03 µmol/L of β-carotene (n=18 detectable cord blood samples), 
and 0.05 ± 0.03 µmol/L and 0.01 ± 0.01 µmol/L of α-carotene (n=8 detectable cord blood 
samples).  Cord retinol concentrations were 53.7% of maternal concentrations.33 
19 
 
From the NHANES III data, the mean serum level of each specific carotenoid was 
reported for adult females.  Women ages 19-30 and 31-50, respectively, had mean β-carotene 
levels of 15.0 and 21.7 µg/dL, mean α-carotene levels of 3.44 and 5.37 µg/dL, mean β-
cryptoxanthin levels of 7.33 and 8.84 µg/dL, mean lutein + zeaxanthin levels of 18.6 and 21.4 
µg/dL, and mean lycopene levels of 24.8 and 22.9 µg/dL.15 
Carotenoid Status – Data Exclusive to Infants Only: 
In a study assessing vitamin A status in 100 cord blood samples from normal birth weight 
infants in Hawaii (mean birth weight was 3411.6 ± 464.3 grams), mean retinol was 209 ± 55 
ng/mL (0.73 ± 0.19 µmol/L), total trans lutein + trans zeaxanthin was 30 ± 16 ng/mL (30 ± 16 
µg/L), α-cryptoxanthin was 5 ± 2 ng/mL (5 ± 2 µg/L), trans-β-cryptoxanthin was 12 ± 15 ng/mL 
(12 ± 15 µg/L), total lycopene was 12 ± 6 ng/mL (12 ± 6 µg/L), trans-α-carotene was 2 ± 2 
ng/mL (2 ± 2 µg/L), trans-β-carotene was 7 ± 17 ng/mL (7 ± 17 µg/L), cis-β-carotene was 0.9 ± 2 
ng/mL (0.9 ± 2 µg/L), and total carotenoids was 99 ± 56 ng/mL (99 ± 56 µg/L).2  Carotenoids 
were also measured in 83 preterm and term infants at birth in Germany in a study by Sommerburg 
et al.  Median plasma concentrations at birth of cryptoxanthin were 11 µg/L (8-12 µg/L), 
lycopene were 16 µg/L (14-18 µg/L), α-carotene were 5 µg/L (0-8 µg/L), and β-carotene were 24 
µg/L (19-31 µg/L).5 
 
MATERNAL VITAMIN A INTAKE 
The nutritional status of mothers throughout pregnancy and at birth is one of the most 
important factors that influence the nutritional status of infants at birth.  Vitamin A stores in 
infants are affected by maternal vitamin A intake while pregnant.37  Changes in maternal vitamin 
A intake affect the circulating vitamin A levels, thus influencing the availability of vitamin A to 
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transfer to the fetus via the placenta.32  Mothers can also influence their infant’s vitamin A status 
postpartum if breast feeding their infant.37 
Little is known about maternal intake of vitamin A during pregnancy.  Weinman et al. 
administered a qualitative questionnaire reflecting intake during gestation to 124 mothers at birth 
in Brazil.  It assessed intake from green, orange or yellow vegetables, fruits, milk, dairy products, 
and meat (liver and fish).  Information on vitamin A supplementation during pregnancy was also 
obtained and showed that 7.3% of mothers took oral vitamin A supplementation.  The 
questionnaire revealed that 74.2% of mothers consumed a satisfactory amount of food rich in 
vitamin A, although the satisfactory criteria was not defined.28   
Another study in Finland by Tammela et al. administered 10-item structured 
questionnaires to 11 mothers of preterm infants with low (<1.05 µmol/L) concentrations of 
vitamin A in cord blood and 25 mothers of preterm infants with normal (>1.05 µmol/L) 
concentrations of vitamin A in cord blood.  The questionnaires assessed the frequency of 
consumption of liver products, carrots and vegetables, and butter and vegetable fats.  The dietary 
habits did not differ between mothers whose infants had low vitamin A concentrations and those 
that had normal vitamin A concentrations.  The questionnaire revealed that 91% of mothers of 
infants with low vitamin A status and 56% of mothers of infants with normal vitamin A status 
consumed liver products 0-1 times/month.  It also showed that 45% of mothers of infants with 
low vitamin A status and 28% of mothers of infants with normal vitamin A status ate carrots 0-1 
times/week.  Vegetables were consumed less than 5 times/week in 18% of mothers of infants with 
low vitamin A status and in 56% of mothers of infants with normal vitamin A status.  Lastly, the 
questionnaire showed that 54% of mothers of infants with low vitamin A status and 44% of 
mothers of infants with normal vitamin A status consumed vegetable fat.26 
In a sample of 683 pregnant mothers in Israel, 24 hour dietary questionnaires were given 
to assess nutritional status during pregnancy.  Mean and median vitamin A intake was 531.0 ± 
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94.1 µg RAE and 237.1 µg RAE, respectively.  The IOM’s EAR of 550 µg RAE was used for 
adequate vitamin A intake.  Of the mothers, 88% had vitamin A intake below the EAR.38 
The NHANES III data estimated the mean vitamin A intake for pregnant women to be 
757 µg RAE/day.  Dietary intake information was also obtained on carotenoids.  Pregnant women 
consumed on average 376 µg of α-carotene, 1531 µg β-carotene, 159 µg β-cryptoxanthin, 1455 
µg lutein + zeaxanthin, and 8713 µg lycopene based on the usual intake from food for one day.10   
 
INFANT VITAMIN A INTAKE 
Estimations of vitamin A intake have been reported in various populations of infants after 
birth.  A prospective cohort of 35 very low birth weight infants (<1500 grams) in Thailand 
estimated vitamin A intake from parenteral nutrition, enteral feedings of breast milk or formula, 
and supplementation.  Median daily vitamin A intake was 1066 IU/day (IQR 893.7-1337 IU/day) 
or 820 IU/kg/day (IQR 698-1122 IU/kg/day) from birth to the time of full feeding.  From time of 
full feeding to term postmenstrual age, the median vitamin A intake was 1585 IU/day (IQR 1169-
1893 IU/day) or 832 IU/kg/day (IQR 516.3-1087 IU/kg/day).  Information was not available to 
differentiate the percentage of vitamin A intake from each source of nutrition.3 
Souza et al. described differences in vitamin A intake between term and preterm infants 
(<37 weeks gestation) who were exclusively breastfed with no supplements by mothers in Brazil.  
Breast milk samples were analyzed to determine the vitamin A intake.  Term and preterm infants 
had an average intake of 352.64 ± 152.72 µg of retinol/day and 217.65 ± 105.65 µg of retinol/day, 
respectively.  With these groups, 46.3% of term and 72.5% of preterm infants did not consume 
adequate amounts of vitamin A, which was defined as 400 µg/day, as established by the IOM’s 
DRIs.  This is likely influenced by the concentration of retinol in the breast milk of mothers who 
had term vs. preterm infants and the volumes consumed.  The mean retinol concentration of 
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breast milk was significantly higher in mothers of term infants (1.87 ± 0.81 µmol/L) compared to 
preterm infants (1.38 ± 0.67 µmol/L) (p<0.0001).39  The American Academy of Pediatrics has 
recommended that preterm infants should consume 210-450 µg retinol/kg each day.14 
In a research study conducted in China, the vitamin A status of infants aged 0-2 months 
was evaluated.  Infants were evaluated based upon their form of nutrition received.  The groups 
included mix-fed, artificially fed, and breast fed infants.  For mix-fed infants, the mean and 
median intakes of vitamin A were 662 ± 12.8 µg/day and 543 µg/day, respectively.  Only 0.4% of 
the infants in this group were inadequate for vitamin A when compared to the EAR in China of 
375 µg/day.  When evaluating possible toxicity levels in mix-fed infants, 38.2% were above the 
UL of 600 µg/day.  Infants who were solely receiving artificial formula had a mean vitamin A 
intake of 627 ± 26.8 µg/day and median intake of 644 µg/day.  The artificially fed group had 
21.5% who did not meet the EAR, but also had over half of the group exceeding the UL (53.5%).  
Breast fed infants had mean vitamin A intakes lower than that of the artificially fed and mix-fed 
infants, although the specific data for this group was not reported.40  
In order to appropriately provide recommendations and care to pregnant women and 
infants to prevent VAD, an evaluation of maternal and infant serum vitamin A compound levels, 
prevalence of VAD, and maternal dietary intake of vitamin A compounds in the United States is 
needed.   
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CHAPTER 3: METHODS 
STUDY DESIGN AND POPULATION 
This prospective cohort was conducted to evaluate vitamin A status in infants and 
mothers at birth.  All infants admitted to the NICU at Nebraska Medicine and their mothers were 
eligible for enrollment.  Written informed consent was obtained from a parent for each infant 
enrolled.  Exclusion criteria included infants with congenital abnormalities, inborn errors of 
metabolism, gastrointestinal, liver, or kidney disease, anemia, and those that required blood 
transfusions.  Infants were also excluded if the parents were under the age of 19 years or if infants 
were made wards of the State of Nebraska.  The study protocol was approved by the University of 
Nebraska Medical Center Institutional Review Board. 
 
DATA AND BLOOD COLLECTION 
Thirty-four mother-infant pairs were enrolled into the study.  Maternal and umbilical cord 
blood samples were collected at the time of delivery.  Samples were processed efficiently after 
collection, protected from heat and light, and stored in -80˚ F freezers until they were analyzed.  
Analysis of samples was performed at the Biomarker Research Institute at the Harvard School of 
Public Health.  Measurements of lutein + zeaxanthin, β-cryptoxanthin, trans-lycopene, cis-
lycopene, total lycopene, α-carotene, trans-β-carotene, cis-β-carotene, total-β-carotene, and 
retinol were obtained.  Concentrations in plasma samples were measured as described by El-
Sohemy et al.  Plasma samples (250 µL) were mixed with 250 mL ethanol containing 10 ug rac-
tocopherol/mL (Tocol) as an internal standard, extracted with 4 mL hexane, evaporated to 
dryness under nitrogen, and reconstituted in 100 mL ethanol-dioxane (1:1, by vol) and 150 mL 
acetonitrile.  Samples are quantitated by high-performance liquid chromatography (HPLC) on a 
Restek Ultra C18 150 mm X 4.6 mm column with a 3-µm particle size encased in a column oven 
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(Hitachi L-2350, Hitachi, San Jose, CA) to prevent temperature fluctuations, and equipped with a 
trident guard cartridge system (Restek, Corp. Bellefonte, PA).  A mixture of acetonitrile, 
tetrahydrofuran, methanol, and a 1% ammonium acetate solution (68:22:7:3) was used as the 
mobile phase at a flow rate of 1.1 mL/min, with a Hitachi L-2130 pump in isocratic mode, a 
Hitachi L-2455 diode array detector (300 nm and 445 nm), and a Hitachi L-2200 auto-sampler 
with water-chilled tray.  The Hitachi System Manager software (D-2000 Elite, Version 3.0) was 
used for peak integration and data acquisition.  Internal quality control was monitored with four 
control samples analyzed within each run.  These samples consisted of two identical high-level 
plasmas and two identical low-level plasmas.  Comparison of data from these samples allowed 
for within-run and between-run variation estimates.  In addition, external quality control was 
monitored by participation in the standardization program for carotenoid analysis from the 
National Institute of Standards and Technology U.S.A.41  
Maternal baseline and clinical data was collected and included race, body mass index 
(BMI), delivery mode, birth month, gestational diabetes mellitus, preeclampsia, placental 
chorioamnionitis, serum vitamin A levels, and dietary intake.  Infant baseline and clinical data 
was collected and included sex, gestational age, birth weight and percentile, birth head 
circumference and percentile, birth length and percentile, ROP, supplemental oxygen use, 
intubation on admission, days on ventilator, BPD, respiratory distress syndrome (RDS), NEC, 
intraventricular hemorrhage (IVH), positive blood cultures, and cord blood vitamin A levels.  A 
subject was noted to have any of the above conditions if a medical diagnosis was made during the 
NICU stay in the electronic medical record. 
Dietary intake throughout pregnancy was assessed by administering food frequency 
questionnaires (FFQ) to the mothers.  The FFQs encompassed typical intake from supplements, 
food from all of the major food groups, and beverages over the past year.  FFQs were analyzed 
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using the Harvard nutrient-composition database which contains food composition values from 
the United States Department of Agriculture. 
VAD was defined according to WHO standards and categories used by Fernandes et al.  
Infants and mothers were considered severely deficient (<0.35 µmol/L or <100 µg/L), deficient 
(0.35-0.70 µmol/L or 100-200 µg/L), low (0.70-1.05 µmol/L or 200-300 µg/L), or adequate 
(>1.05 µmol/L or >300 µg/L) based upon their serum retinol levels.8,25,29  Other investigators 
have used similar concentrations as an indicator of VAD in infants and pregnant women.1,3,20,25,26 
 
STATISTICAL ANALYSIS 
Descriptive statistics were used for continuous and categorical variables.  Continuous 
variables (maternal BMI, serum vitamin A levels, and dietary intake information and infant 
gestational age, birth weight and percentile, birth head circumference and percentile, birth length 
and percentile, days on ventilator, and serum vitamin A levels) were described using means ± 
standard deviations, medians, and ranges.  For categorical variables (maternal race, delivery 
mode, birth month, gestational diabetes mellitus, preeclampsia, and placental chorioamnionitis 
and infant sex, ROP, supplemental oxygen use, intubation on admission, BPD, RDS, NEC, IVH, 
and positive blood cultures), frequencies and percentages were reported. 
Retinol levels were measured in µg/L and converted to µmol/L to reflect adequacy and 
deficiency standards established by WHO.  The conversion factor used was 286 µg retinol is 
equivalent to 1 µmol retinol.19  Conversion factors were also used for carotenoids to make 
comparisons to previous research findings according to the NHANES 2005-2006 data processing 
protocol.  The following conversions factors were used: 
 Lutein + zeaxanthin results in µg/L were converted into µmol/L by multiplying by 
0.001758 
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 β-cryptoxanthin results in µg/L were converted into µmol/L by multiplying by 0.001810 
 Lycopene results in µg/L were converted into µmol/L by multiplying by 0.001863 
 α-carotene results in µg/L were converted into µmol/L by multiplying by 0.001863 and 
 β-carotene results in µg/L were converted into µmol/L by multiplying by 0.001863.42 
Spearman correlation coefficients were used to describe associations between maternal 
and cord blood vitamin A levels, maternal dietary intake and maternal and cord blood vitamin A 
levels, gestational age and maternal and cord blood vitamin A levels, and birth weight and 
maternal and cord blood vitamin A levels.   
All tests were two-sided and a P-value <0.05 was considered statistically significant.  All 
statistical analyses were carried out using the Statistical Package for the Social Sciences software 
(IBM SPSS Statistics; Version 22.0). 
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CHAPTER 4: RESULTS 
SUBJECT CHARACTERISTICS 
Maternal and infant demographics and clinical information were obtained for all 34 
mother-infant pairs.  Characteristics of the study mothers and infants are presented in Tables 2-3. 
Maternal Characteristics 
Of the mothers enrolled, 64.7% were Caucasian, 17.6% Hispanic, 14.7% African 
American, and 2.9% other/unknown race.  Gestational diabetes mellitus, preeclampsia, and 
placental chorioamnionitis were present in 17.6%, 20.6%, and 11.8% of mothers, respectively.  
The mean BMI was 30.7 ± 6.3 kg/m2.  Vaginal deliveries occurred in 47.1% of the births.  All of 
the births took place in the summer (29.4% in June, 41.2% in July, and 29.4% in August). 
Infant Characteristics 
The group of infants was comprised of 58.8% males and 41.2% females.  The mean 
gestational age was 36.7 ± 3.4 weeks.  The mean birth weight was 2738.0 ± 835.7 gm (45.5 ± 
33.3 %ile), mean length was 47.0 ± 4.6 cm (47.2 ± 34.4 %ile), and mean head circumference was 
32.3 ± 2.6 cm (45.4 ± 33.5 %ile).  Development of complications after birth in the infants 
included ROP (2.9%), RDS (38.2%), BPD (2.9%), intubation on admission (26.5%), 
supplemental oxygen use (41.2%), and a positive blood culture result (2.9%).  Nine subjects were 
on a ventilator for an average of 2.0 ± 2.3 days throughout their NICU stay.   
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Table 2: Maternal Baseline Characteristics 
 
Categorical Demographics (n=34) n (%)     
Race    
Caucasian 22 (64.7)   
Hispanic 6 (17.6)   
African American 5 (14.7)   
Other/Unknown 1 (2.9)   
Delivery Mode    
Vaginal 16 (47.1)   
Cesarean 18 (52.9)   
Birth Month    
June 10 (29.4)   
July 14 (41.2)   
August 10 (29.4)   
Gestational Diabetes Mellitus 6 (17.6)   
Preeclampsia 7 (20.6)   
Placental Chorioamnionitis 4 (11.8)     
Continuous Demographics  Mean ± SD Median Range 
BMI (kg/m2) (n=34) 30.7 ± 6.3 29.6 18.0-42.1 
Serum Vitamin A Levels (n=31)    
lutein + zeaxanthin (µg/L) 163.3 ± 91.7 140.3 45.1-443.8 
β-cryptoxanthin (µg/L) 73.5 ± 53.0 59.9 8.7-285.7 
trans-lycopene (µg/L) 243.9 ± 107.4 222.8 35.6-438.5 
cis-lycopene (µg/L) 200.9 ± 81.4 194.9 36.7-378.8 
total lycopene (µg/L) 444.9 ± 186.2 424.1 72.3-795.8 
α-carotene (µg/L) 48.4 ± 72.9 18.1 4.6-388.4 
trans-β-carotene (µg/L) 186.4 ± 221.6 104.6 21.4-968.9 
cis-β-carotene (µg/L) 14.5 ± 16.1 7.5 1.7-67.8 
total-β-carotene (µg/L) 200.9 ± 237.5 113.2 23.1-1036.7 
retinol (µg/L) 326.3 ± 140.8 288.2 146.5-648.9 
retinol (µmol/L) 1.14 ± 0.49 1.01 0.51-2.27 
Dietary Intake (n=20)    
Calorie Intake (kcals) 2600.3 ± 991.3 2323.7 1314.0-4415.6 
Protein Intake (gm) 104.1 ± 32.3 108.7 44.9-157.4 
Carbohydrate Intake (gm) 343.1 ± 157.5 299.0 165.6-710.7 
Fat Intake (gm) 95.1 ± 35.4 89.9 39.0-161.7 
Retinol Activity  
                  Equivalents (RAE) (µg) 
1799.9 ± 613.6 1937.4 422.3-2721.7 
lutein + zeaxanthin (µg) 2761.7 ± 1894.5 2060.2 852.4-6937.0 
β-cryptoxanthin (µg) 218.5 ± 183.2 130.7 45.0-629.5 
total lycopene (µg) 5362.8 ± 5273.4 3637.2 1072.0-24654.1 
α-carotene (µg) 620.5 ± 1056.6 267.8 17.4-4719.5 
total-β-carotene (µg) 5039.2 ± 3806.7 4336.6 430.8-15661.6 
retinol (IU) 3403.6 ± 1837.1 3243.3 756.1-7490.8 
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Table 3: Infant Baseline Characteristics 
 
Categorical Demographics (n=34) n (%)     
Sex    
Male 20 (58.8)   
Female 14 (41.2)   
Retinopathy of Prematurity (ROP)  1 (2.9)   
Supplemental Oxygen Use 14 (41.2)   
Intubation on Admission 9 (26.5)   
Bronchopulmonary Dysplasia (BPD) 1 (2.9)   
Respiratory Distress Syndrome (RDS) 13 (38.2)   
Necrotizing Enterocolitis (NEC) 0 (0)   
Intraventricular hemorrhage (IVH) 0 (0)   
Positive blood culture 1 (2.9)     
Continuous Demographics (n=34)   Mean ± SD Median Range 
Gestational Age (weeks) 36.7 ± 3.4 37.1 30.3-42.0 
Birth weight (gm) 2738.0 ± 835.7 2850.0 840.0-4109.0 
Birth weight Percentile 45.5 ± 33.3 43.4 0.0-98.8 
Birth Head Circumference (cm) 32.3 ± 2.6 32.7 25.0-37.0 
Birth Head Circumference Percentile 45.4 ± 33.5 43.3 0.0-99.6 
Birth Length (cm) 47.0 ± 4.6 47.0 35.0-55.0 
Birth Length Percentile 47.2 ± 34.4 48.5 0.0-99.7 
Days on Ventilator (n=9) 2.0 ± 2.3 1.0 1.0-8.0 
Cord Blood Vitamin A Levels (n=32)    
lutein + zeaxanthin (µg/L) 25.4 ± 11.4 24.6 9.5-57.7 
β-cryptoxanthin (µg/L) 9.3 ± 5.7 7.9 2.4-25.8 
trans-lycopene (µg/L) 11.5 ± 6.3 10.5 3.6-26.0 
cis-lycopene (µg/L) 10.3 ± 5.3 9.2 2.9-24.0 
total lycopene (µg/L) 21.8 ± 11.4 19.5 6.5-48.5 
α-carotene (µg/L) 5.4 ± 4.5 4.5 0.0-18.8 
trans-β-carotene (µg/L) 15.1 ± 15.4 10.1 0.0-70.3 
cis-β-carotene (µg/L) 3.1 ± 2.5 2.3 0.0-10.0 
total-β-carotene (µg/L) 18.3 ± 17.3 12.4 0.0-75.9 
retinol (µg/L) 172.0 ± 43.0 180.5 98.1-255.9 
retinol (µmol/L) 0.60 ± 0.15 0.63 0.34-0.89 
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VITAMIN A STATUS 
Maternal and cord blood samples were collected and analyzed for 31 mothers and 32 
infants.  Maternal and cord blood levels are displayed in Tables 2-3.  Vitamin A status of mothers 
and infants according to WHO classification is shown in Table 4 and Figure 4.  
Maternal Status 
The mean maternal serum retinol level was 326.3 ± 140.8 µg/L (1.14 ± 0.50 µmol/L).  
Categorical placement of retinol levels revealed 41.9%, 45.2%, and 12.9% of mothers had 
adequate, low, and deficient vitamin A status, respectively.  The mean lutein + zeaxanthin level 
was 163.3 ± 91.7 µg/L, β-cryptoxanthin was 73.5 ± 53.0 µg/L, trans-lycopene was 243.9 ± 107.4 
µg/L, cis-lycopene was 200.9 ± 81.4 µg/L, total lycopene was 444.9 ± 186.2 µg/L, α-carotene 
was 48.4 ± 72.9 µg/L, trans-β-carotene was 186.4 ± 221.6 µg/L, cis-β-carotene was 14.5 ± 16.1 
µg/L, and total-β-carotene was 200.9 ± 237.5 µg/L.      
Infant Status 
At birth, 71.9% of infants were vitamin A deficient with 3.1% of those being severely 
deficient.  The remaining 28.1% of infants had low vitamin A status.  None of the subjects had 
levels >1.05 µmol/L.  The mean cord retinol level was 172.0 ± 43.0 µg/L (0.60 ± 0.15 µmol/L).  
The mean lutein + zeaxanthin level was 25.4 ± 11.4 µg/L, β-cryptoxanthin was 9.3 ± 5.7 µg/L, 
trans-lycopene was 11.5 ± 6.3 µg/L, cis-lycopene was 10.3 ± 5.3 µg/L, total lycopene was 21.8 ± 
11.4 µg/L, α-carotene was 5.4 ± 4.5 µg/L, trans-β-carotene was 15.1 ± 15.4 µg/L, cis-β-carotene 
was 3.1 ± 2.5 µg/L, and total-β-carotene was 18.3 ± 17.3 µg/L. 
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Table 4: Prevalence of Vitamin A Deficiency 
 
Infants (n = 32) n (%) 
     Severely Deficient  
          (<0.35 µmol/L or <100 µg/L) 
1 (3.1) 
     Deficient   
          (0.35-0.70 µmol/L or 100-200 µg/L) 
22 (68.8) 
     Low   
          (0.70-1.05 µmol/L  or 200-300 µg/L) 
9 (28.1) 
     Adequate  
          (>1.05 µmol/L or >300 µg/L) 
0 (0) 
    
Mothers (n = 31)   
     Severely Deficient  
          (<0.35 µmol/L or <100 µg/L) 
0 (0) 
     Deficient   
          (0.35-0.70 µmol/L or 100-200 µg/L) 
4 (12.9) 
     Low   
          (0.70-1.05 µmol/L  or 200-300 µg/L) 
14 (45.2) 
     Adequate  
          (>1.05 µmol/L or >300 µg/L) 
13 (41.9) 
 
Figure 4: Maternal and Infant Serum Vitamin A Status 
 
 
Figure 4: Maternal and Infant Serum Vitamin A Status.  Maternal and infant retinol levels categorized 
into severely deficient, deficient, low, and adequate vitamin A status. 
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Relationship between Serum Vitamin A Levels of Mothers and Infants:  
Associations between maternal and cord blood were determined and are displayed in 
Table 5.  Levels were positively correlated for lutein + zeaxanthin (r=0.50, p=0.004), β-
cryptoxanthin (r=0.83, p=<0.001), trans-lycopene (r=0.68, p=<0.001), cis-lycopene (r=0.52, 
p=0.003), total lycopene (r=0.63, p=<0.001), α-carotene (r=0.67, p=<0.001), trans-β-carotene 
(r=0.74, p=<0.001), cis-β-carotene (r=0.44, p=0.013), total-β-carotene (r=0.71, p=<0.001), and 
retinol (r=0.42, p=0.018).  Figures 5-10 display the significant correlations for the main 
carotenoids (lutein + zeaxanthin, β-cryptoxanthin, total lycopene, α-carotene, and total-β-
carotene) and retinol. 
 
 
Table 5: Correlations of Maternal and Infant Vitamin A Concentrations  
 
 Correlation Coefficient P-value 
lutein + zeaxanthin (µg/L) 0.50 0.004 
β-cryptoxanthin (µg/L) 0.83 <0.001 
trans-lycopene (µg/L) 0.68 <0.001 
cis-lycopene (µg/L) 0.52 0.003 
total lycopene (µg/L) 0.63 <0.001 
α-carotene (µg/L) 0.67 <0.001 
trans-β-carotene (µg/L) 0.74 <0.001 
cis-β-carotene (µg/L) 0.44 0.013 
total-β-carotene (µg/L) 0.71 <0.001 
retinol (µg/L) 0.42 0.018 
 
 
 
 
 
33 
 
Figure 5: Relationship of Maternal-Infant Serum Lutein + Zeaxanthin 
Concentrations 
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Figure 5: Relationship of Maternal-Infant Serum Lutein + Zeaxanthin 
Concentrations.  Positive correlation between maternal and infant cord blood lutein + 
zeaxanthin levels (r=0.50; p=0.004). 
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Figure 6: Relationship of Maternal-Infant Serum β-Cryptoxanthin Concentrations 
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Figure 6: Relationship of Maternal-Infant Serum β-Cryptoxanthin Concentrations.  
Positive correlation between maternal and infant cord blood β-cryptoxanthin levels 
(r=0.83; p=<0.001). 
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Figure 7: Relationship of Maternal-Infant Serum Total Lycopene Concentrations 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Relationship of Maternal-Infant Serum Total Lycopene Concentrations.  
Positive correlation between maternal and infant cord blood total lycopene levels (r=0.63; 
p=<0.001). 
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Figure 8: Relationship of Maternal-Infant Serum α-Carotene Concentrations 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Relationship of Maternal-Infant Serum α-Carotene Concentrations.  Positive 
correlation between maternal and infant cord blood α-Carotene levels (r=0.67; p=<0.001). 
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Figure 9: Relationship of Maternal-Infant Serum Total-β-Carotene Concentrations 
 
 
 
Figure 9: Relationship of Maternal-Infant Serum Total-β-Carotene Concentrations. 
Positive correlation between maternal and infant cord blood total β-carotene levels (r=0.71; 
p=<0.001). 
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Figure 10: Relationship of Maternal-Infant Serum Retinol Concentrations 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Relationship of Maternal-Infant Serum Retinol Concentrations.  Positive 
correlation between maternal and infant cord blood retinol levels (r=0.42; p=0.018). 
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Positive significant associations between birth weight and maternal serum vitamin A 
concentrations were found for β-cryptoxanthin (r=0.36, p=0.048), α-carotene (r=0.44, p=0.012), 
trans-β-carotene (r=0.48, p=0.007), cis-β-carotene (r=0.50, p=0.004), and total-β-carotene 
(r=0.49, p=0.005).  Table 6 displays all correlations between birth weight and maternal serum 
vitamin A concentrations.  Figures 11-13 illustrate the associations between the main carotenoids 
(β-cryptoxanthin, α-carotene, and total-β-carotene) with significant correlations.  Significant 
associations between birth weight and cord blood concentrations were also found for β-
cryptoxanthin (r=0.39, p=0.026), α-carotene (r=0.36, p=0.042), trans-β-carotene (r=0.42, 
p=0.015), cis-β-carotene (r=0.44, p=0.012), total-β-carotene (r=0.44, p=0.012), and retinol 
(r=0.73, p=<0.001).  All correlations are shown in Table 7 for birth weight and cord blood 
concentrations.  Retinol was most strongly associated with birth weight and is presented in Figure 
14.   
 
Table 6: Correlations of Birth Weight and Maternal Vitamin A Concentrations 
 
 Correlation Coefficient P-value 
lutein + zeaxanthin (µg/L) 0.34 0.065 
β-cryptoxanthin (µg/L) 0.36 0.048 
trans-lycopene (µg/L) -0.12 0.532 
cis-lycopene (µg/L) -0.08 0.665 
total lycopene (µg/L) -0.11 0.570 
α-carotene (µg/L) 0.44 0.012 
trans-β-carotene (µg/L) 0.48 0.007 
cis-β-carotene (µg/L) 0.50 0.004 
total-β-carotene (µg/L) 0.49 0.005 
retinol (µg/L) 0.17 0.361 
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Figure 11: Relationship of Birth Weight and Maternal β-Cryptoxanthin 
Concentrations  
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Relationship of Birth Weight and Maternal β-Cryptoxanthin 
Concentrations. Positive correlation between birth weight and maternal serum  
β-cryptoxanthin levels (r=0.36; p=0.048). 
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Figure 12: Relationship of Birth Weight and Maternal α-Carotene Concentrations  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Relationship of Birth Weight and Maternal α-Carotene Concentrations. 
Positive correlation between birth weight and maternal serum α-carotene levels (r=0.44; 
p=0.012). 
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Figure 13: Relationship of Birth Weight and Maternal Total-β-Carotene 
Concentrations  
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Relationship of Birth Weight and Maternal Total-β-Carotene 
Concentrations.  Positive correlation between birth weight and maternal serum total-β-
carotene levels (r=0.49; p=0.005). 
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Table 7: Correlations of Birth Weight and Infant Vitamin A Concentrations 
 
 Correlation Coefficient P-value 
lutein + zeaxanthin (µg/L) 0.21 0.250 
β-cryptoxanthin (µg/L) 0.39 0.026 
trans-lycopene (µg/L) -0.11 0.553 
cis-lycopene (µg/L) -0.10 0.600 
total lycopene (µg/L) -0.07 0.715 
α-carotene (µg/L) 0.36 0.042 
trans-β-carotene (µg/L) 0.42 0.015 
cis-β-carotene (µg/L) 0.44 0.012 
total-β-carotene (µg/L) 0.44 0.012 
retinol (µg/L) 0.73 <0.001 
 
 
 
Figure 14: Relationship of Birth Weight and Infant Retinol Concentrations 
 
 
 
 
 
Figure 14: Relationship of Birth Weight and Infant Retinol Concentrations.  Positive 
correlation between birth weight and cord blood retinol levels (r=0.73; p=0.005). 
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Gestational age and maternal β-cryptoxanthin was significantly positively correlated 
(r=0.39, p=0.031) (Figure 15) as well as gestational age and infant β-cryptoxanthin (r=0.39, 
p=0.026), cis-β-carotene (r=0.37, p=0.039), and retinol (r=0.55, p=0.001) (Figure 16).  Table 8 
and Table 9 show all correlations between gestational age and serum vitamin A concentrations for 
mothers and infants, respectively.   
 
 
Table 8: Correlations of Gestational Age and Maternal Vitamin A Concentrations 
 
 Correlation Coefficient P-value 
lutein + zeaxanthin (µg/L) 0.23 0.221 
β-cryptoxanthin (µg/L) 0.39 0.031 
trans-lycopene (µg/L) -0.11 0.571 
cis-lycopene (µg/L) -0.09 0.636 
total lycopene (µg/L) -0.11 0.568 
α-carotene (µg/L) 0.22 0.236 
trans-β-carotene (µg/L) 0.27 0.144 
cis-β-carotene (µg/L) 0.35 0.053 
total-β-carotene (µg/L) 0.28 0.123 
retinol (µg/L) -0.12 0.519 
 
 
 
 
 
 
 
 
 
Maternal Blood Levels (µg/L) 
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Figure 15: Relationship of Gestational Age and Maternal β-Cryptoxanthin 
Concentrations 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Relationship of Gestational Age and Maternal β-Cryptoxanthin 
Concentrations. Positive correlation between gestational age and maternal serum β-
cryptoxanthin levels (r=0.39; p=0.031). 
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Table 9: Correlations of Gestational Age and Infant Vitamin A Concentrations 
 
 Correlation Coefficient P-value 
lutein + zeaxanthin (µg/L) 0.25 0.173 
β-cryptoxanthin (µg/L) 0.39 0.026 
trans-lycopene (µg/L) 0.01 0.949 
cis-lycopene (µg/L) 0.02 0.929 
total lycopene (µg/L) 0.04 0.826 
α-carotene (µg/L) 0.18 0.323 
trans-β-carotene (µg/L) 0.31 0.083 
cis-β-carotene (µg/L) 0.37 0.039 
total-β-carotene (µg/L) 0.33 0.063 
retinol (µg/L) 0.55 0.001 
 
 
Figure 16: Relationship of Gestational Age and Infant Retinol Concentrations  
 
 
 
 
Figure 16: Relationship of Gestational Age and Infant Retinol Concentrations.  Positive 
correlation between gestational age and cord blood retinol levels (r=0.55; p=0.001). 
  
In
fa
n
t 
R
e
ti
n
o
l 
(µ
g
/L
) 
 
Gestational Age (weeks) 
 
47 
 
MATERNAL VITAMIN A INTAKE 
FFQs were completed for 21 mothers, but data from 20 FFQs were used for analysis 
(Table 2).  FFQ data from one mother was excluded due to results of calorie intake (31727 kcals) 
exceeding expected amount.  The median daily energy intake was 2323.7 kcals (1314.0-4415.6 
kcals).  Median macronutrient intake of protein, carbohydrates, and fat were 108.7 gm (44.9-
157.4 gm), 299.0 gm (165.6-710.7 gm), and 89.9 gm (39.0-161.7 gm), respectively.  Median 
daily RAE was 1937.4 µg (422.3-2721.7 µg).  Median retinol intake was 3243.3 IU (756.1-
7490.8 IU.  Specific median carotenoid intake was 2060.2 µg (52.4-6937.0 µg) of lutein + 
zeaxanthin, 130.7 µg (45.0-629.5 µg) of β-cryptoxanthin, 3637.2 µg (1072.0-24654.1 µg) of 
lycopene, 267.8 µg (17.4-4719.5 µg) of α-carotene, and 4336.6 µg (430.8-15661.6 µg) of β-
carotene. 
Correlations between dietary intake and maternal and cord blood concentrations of 
vitamin A compounds are displayed in Tables 10-11.  Maternal intake of specific vitamin A 
forms was found to be significantly associated with maternal and cord blood levels.  Intake of 
lutein + zeaxanthin was positively associated with maternal serum α-carotene (r=0.47, p=0.047) 
and β-carotene (r=0.48, p=0.045).  Dietary α-carotene was positively associated with maternal 
serum α-carotene (r=0.52, p=0.029).  β-carotene intake was also positively associated with 
maternal serum β-carotene (r=0.47, p=0.050) and α-carotene (r=0.50, p=0.034).  One significant 
negative association was found between RAE intake and maternal serum β-cryptoxanthin (r=-
0.51, p=0.031).  Maternal intake of lutein + zeaxanthin and β-carotene was significantly 
correlated with cord blood α-carotene levels (r=0.55, p=0.015 and r=0.63, p=0.004, respectively). 
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Table 10: Correlations of Maternal Intake of Vitamin A and Maternal Blood Levels 
  
Dietary intake vs. Serum Level 
Correlation 
Coefficient 
P-value 
(*significant) 
lutein + zeaxanthin (µg) vs. lutein + zeaxanthin (µg/L) 0.31 0.205 
lutein + zeaxanthin (µg) vs.  β-cryptoxanthin (µg/L) 0.27 0.278 
lutein + zeaxanthin (µg) vs. total lycopene (µg/L) -0.15 0.550 
lutein + zeaxanthin (µg) vs. α-carotene (µg/L) 0.47 0.047* 
lutein + zeaxanthin (µg) vs. total-β-carotene (µg/L)  0.48 0.045* 
lutein + zeaxanthin (µg) vs. retinol (µg/L) -0.05 0.858 
β-cryptoxanthin (µg) vs. β-cryptoxanthin (µg/L) 0.16 0.518 
β-cryptoxanthin (µg) vs. lutein + zeaxanthin (µg/L) -0.11 0.677 
β-cryptoxanthin (µg) vs. total lycopene (µg/L) 0.27 0.281 
β-cryptoxanthin (µg) vs. α-carotene (µg/L) -0.12 0.633 
β-cryptoxanthin (µg) vs. total-β-carotene (µg/L)  -0.02 0.942 
β-cryptoxanthin (µg) vs. retinol (µg/L) -0.07 0.772 
lycopene (µg) vs. total lycopene (µg/L) 0.38 0.119 
lycopene (µg) vs. lutein + zeaxanthin (µg/L) 0.19 0.458 
lycopene (µg) vs. β-cryptoxanthin (µg/L) 0.21 0.404 
lycopene (µg) vs. α-carotene (µg/L) 0.14 0.573 
lycopene (µg) vs. total-β-carotene (µg/L)  0.31 0.216 
lycopene (µg) vs. retinol (µg/L) 0.09 0.738 
α-carotene (µg) vs. α-carotene (µg/L) 0.52 0.029* 
α-carotene (µg) vs. lutein + zeaxanthin (µg/L) 0.33 0.188 
α-carotene (µg) vs. β-cryptoxanthin (µg/L) 0.13 0.598 
α-carotene (µg) vs. total lycopene (µg/L) -0.17 0.499 
α-carotene (µg) vs. total-β-carotene (µg/L)  0.46 0.058 
α-carotene (µg) vs. retinol (µg/L) 0.32 0.203 
β-carotene (µg) vs. total-β-carotene (µg/L)  0.47 0.050* 
β-carotene (µg) vs. lutein + zeaxanthin (µg/L) 0.25 0.326 
β-carotene (µg) vs. β-cryptoxanthin (µg/L) 0.19 0.450 
β-carotene (µg) vs. total lycopene (µg/L) -0.16 0.407 
β-carotene (µg) vs. α-carotene (µg/L) 0.50 0.034* 
β-carotene (µg) vs. retinol (µg/L) 0.28 0.263 
retinol (IU) vs. retinol (µg/L) -0.07 0.779 
retinol (IU) vs. lutein + zeaxanthin (µg/L) -0.20 0.435 
retinol (IU) vs. β-cryptoxanthin (µg/L) -0.18 0.486 
retinol (IU) vs. total lycopene (µg/L) -0.22 0.378 
retinol (IU) vs. α-carotene (µg/L) -0.14 0.592 
retinol (IU) vs. total-β-carotene (µg/L)  -0.03 0.909 
RAE  (µg) vs. lutein + zeaxanthin (µg/L) -0.30 0.222 
RAE  (µg) vs. β-cryptoxanthin (µg/L) -0.51 0.031* 
RAE  (µg) vs. total lycopene (µg/L) 0.03 0.906 
RAE  (µg) vs. α-carotene (µg/L) 0.00 0.997 
RAE  (µg) vs. total-β-carotene (µg/L)  0.06 0.804 
RAE  (µg) vs. retinol (µg/L) 0.14 0.581 
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Table 11: Correlations of Maternal Intake of Vitamin A and Cord Blood Levels  
 
Dietary intake vs. Serum Level 
Correlation 
Coefficient 
P-value 
(*significant) 
lutein + zeaxanthin (µg) vs. lutein + zeaxanthin (µg/L) 0.09 0.726 
lutein + zeaxanthin (µg) vs.  β-cryptoxanthin (µg/L) 0.22 0.359 
lutein + zeaxanthin (µg) vs. total lycopene (µg/L) -0.09 0.716 
lutein + zeaxanthin (µg) vs. α-carotene (µg/L) 0.55 0.015* 
lutein + zeaxanthin (µg) vs. total-β-carotene (µg/L)  0.39 0.103 
lutein + zeaxanthin (µg) vs. retinol (µg/L) 0.29 0.226 
β-cryptoxanthin (µg) vs. β-cryptoxanthin (µg/L) 0.01 0.977 
β-cryptoxanthin (µg) vs. lutein + zeaxanthin (µg/L) -0.09 0.729 
β-cryptoxanthin (µg) vs. total lycopene (µg/L) 0.04 0.875 
β-cryptoxanthin (µg) vs. α-carotene (µg/L) -0.03 0.901 
β-cryptoxanthin (µg) vs. total-β-carotene (µg/L)  -0.16 0.518 
β-cryptoxanthin (µg) vs. retinol (µg/L) -0.16 0.502 
lycopene (µg) vs. total lycopene (µg/L) 0.06 0.814 
lycopene (µg) vs. lutein + zeaxanthin (µg/L) 0.26 0.288 
lycopene (µg) vs. β-cryptoxanthin (µg/L) 0.23 0.351 
lycopene (µg) vs. α-carotene (µg/L) 0.05 0.844 
lycopene (µg) vs. total-β-carotene (µg/L)  0.05 0.836 
lycopene (µg) vs. retinol (µg/L) 0.17 0.488 
α-carotene (µg) vs. α-carotene (µg/L) 0.34 0.149 
α-carotene (µg) vs. lutein + zeaxanthin (µg/L) 0.12 0.616 
α-carotene (µg) vs. β-cryptoxanthin (µg/L) 0.15 0.542 
α-carotene (µg) vs. total lycopene (µg/L) -0.29 0.232 
α-carotene (µg) vs. total-β-carotene (µg/L)  0.18 0.450 
α-carotene (µg) vs. retinol (µg/L) 0.23 0.355 
β-carotene (µg) vs. total-β-carotene (µg/L)  0.38 0.110 
β-carotene (µg) vs. lutein + zeaxanthin (µg/L) 0.06 0.803 
β-carotene (µg) vs. β-cryptoxanthin (µg/L) 0.24 0.333 
β-carotene (µg) vs. total lycopene (µg/L) -0.13 0.611 
β-carotene (µg) vs. α-carotene (µg/L) 0.63 0.004* 
β-carotene (µg) vs. retinol (µg/L) 0.27 0.257 
retinol (IU) vs. retinol (µg/L) -0.01 0.969 
retinol (IU) vs. lutein + zeaxanthin (µg/L) 0.00 0.997 
retinol (IU) vs. β-cryptoxanthin (µg/L) -0.07 0.770 
retinol (IU) vs. total lycopene (µg/L) -0.23 0.355 
retinol (IU) vs. α-carotene (µg/L) -0.32 0.179 
retinol (IU) vs. total-β-carotene (µg/L)  0.02 0.943 
RAE  (µg) vs. lutein + zeaxanthin (µg/L) -0.09 0.710 
RAE  (µg) vs. β-cryptoxanthin (µg/L) -0.29 0.223 
RAE  (µg) vs. total lycopene (µg/L) 0.07 0.764 
RAE  (µg) vs. α-carotene (µg/L) -0.04 0.864 
RAE  (µg) vs. total-β-carotene (µg/L)  0.11 0.658 
RAE  (µg) vs. retinol (µg/L) 0.11 0.658 
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CHAPTER 5: DISCUSSION 
VITAMIN A STATUS IN MOTHERS AND INFANTS 
The mean retinol level in infants, indicative of vitamin A adequacy or deficiency, was 
172.0 µg/L (0.60 µmol/L).  This is considered deficient according to WHO standards.8  None of 
the infants had adequate levels >1.05 µmol/L.  These findings are concerning considering WHO 
has not acknowledged VAD as a problem and has not evaluated the prevalence in infants or 
preschool-age children in the United States.  Some studies evaluating infants with mean normal 
birth weights or mean gestational ages >37 weeks, similar to our subjects, have reported retinol 
cord levels of 0.49-0.73 µmol/L in the United States (Hawaii), China, and India,2,20,43 which are 
consistent with our findings.  Others have found higher levels at 0.90-1.29 µmol/L in Germany, 
Brazil, and Ireland.18,24,25,33  Preterm infants have even been found to have higher levels ranging 
from 1.19-1.29 µmol/L in Finland.26  Very low or low birth weight infants, though, have been 
found to be deficient with cord blood concentrations of 0.47-0.54 µmol/L in India and 
Thailand.3,43  Retinol concentrations in cord blood are still variable throughout the world and 
between infants of different birth weights and gestational ages.  It has been proposed that the 
normal retinol concentration for newborn infants is between 0.7-2.5 µmol/L.44  Assessing levels 
in the United States, especially different regions of the country, will help define the level of 
public health significance and thus allow health professionals to appropriately screen and provide 
interventions to prevent or treat VAD. 
VAD is more prevalent than expected in the infants in our study.  The prevalence of 
VAD when defined as serum retinol concentrations <0.70 µmol/L has been previously reported to 
affect 23.1-49.3% of infants with normal birth weights and gestational ages in Brazil, China, and 
South Africa,20,25,34 3.6% of infants <33 weeks gestational age in Finland,26 and 67.7% of very 
low birth weight infants in Thailand.3  In addition, 45.5% of healthy infants in Brazil had VAD 
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when retinol levels were <1.05 µmol/L.24  Roughly 3 out of 4 infants in our study had VAD, 
despite nearly 42% of mothers having adequate retinol levels.  Low retinol levels in infants at 
birth could be expected because the fetal liver is only able to store a small amount of vitamin A 
during pregnancy,14 but does not explain the degree of deficiency in our study.   
The maternal-fetal placental transfer was 53%, consistent with 52-55% placental transfers 
previously reported33,43,44 and a proposed estimated ratio of maternal to fetal plasma 
concentrations in healthy pregnancies of 2:1.1  Cord retinol levels at 50-60% of maternal levels 
have been suggested to represent a normal range for infants at birth.44  Researchers in Brazil and 
China, though, have reported higher retinol placental transfer rates of 75-78%.20,24,25  Even when 
comparing infants of low and normal birth weights, rates have not varied between the two groups.  
Agarwal et al. discovered a placental transfer of 34% in low birth weight infants and 37% in 
normal birth weight infants, both findings much lower than the results of our study.35 
 WHO has expanded the serum range for what is considered deficient to include those 
with retinol levels <0.70 µmol/L, which identifies more mothers and infants with VAD.   This 
cutoff value was raised from <0.35 µmol/L in 1996 after members of WHO thought it was too 
low to identify those with subclinical signs of deficiency.23  It has been suggested that defining 
VAD as retinol levels <0.70 µmol/L may not apply for mothers and infants right after delivery 
due to the acute phase response as a result of the birth process and the hemodilution of 
pregnancy.34  However, this change appears to be appropriate as even a subclinical deficiency that 
can be present with retinol levels <0.70 µmol/L has been shown to negatively impact health and 
increase the risk of infections, reduce growth, and decrease survival from serious illnesses.21  
Early identification could lead to earlier interventions and potentially improve health outcomes.  
Even a low vitamin A level should be acted upon to decrease the likelihood of a deficiency from 
developing, especially in infants.  Infants already have low liver stores at birth to begin with and 
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these can be quickly depleted in a couple of days if experiencing a sudden stressful health event, 
malabsorption state, or fasting state.14   
In mothers, low retinol levels throughout pregnancy influence the developing fetus and 
contribute to VAD in infants at birth.  The mean maternal retinol level in our study was 326.3 
µg/L (1.14 µmol/L).  Despite this adequate vitamin A concentration, nearly 13% of mothers were 
deficient (<0.70 µmol/L), with another 45% with low levels (0.70-1.05 µmol/L).  This is 
especially concerning given the placental transfer is only approximately 50%.  A few studies have 
found similar maternal retinol levels between 1.13-1.23 µmol/L18,20,36 while others have found 
higher concentrations of 1.33-1.88 µmol/L24,25,33,43 including the NHANES III data where 
pregnant women had mean retinol levels of 1.47 µmol/L, reflective of the United States 
population.10  Retinol levels in mothers in our study and previous research appear to be variable, 
which may be a result of environmental factors such as vitamin A intake.  It may be crucial to 
evaluate maternal nutritional status throughout pregnancy in order to optimize vitamin A intake 
and thus vitamin A status in the mother and the developing fetus.   
Carotenoid Status: 
 The carotenoid status in mothers and infants at birth has not been evaluated nearly to the 
extent that retinol levels have been, especially in the United States.  Reference intervals are not 
currently established for carotenoid concentrations in plasma.  There is no data available to our 
knowledge reporting maternal and infant carotenoid concentrations in the Midwest region.  All 
carotenoids evaluated were measurable in all subjects except one who had undectable levels of α-
carotene and β-carotene.  Weber et al. was unable to detect zeaxanthin, β-cryptoxanthin, and 
lycopene levels in their cord blood samples.18  Over half the subjects in a study by Kiely et al. 
also had undectable levels of lycopene, β-carotene, and α-carotene.33  Being able to identify levels 
of all of the carotenoids in nearly all of the subjects may be a result of improvements in 
technology used or be reflective of truly higher carotenoid levels in our sample. 
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Compared to data obtained in Hawaii, this study demonstrated lower lutein + zeaxanthin 
levels (25.4 µg/L vs. 30 µg/L) in infants, although Franke et al. measured the trans form only and 
not total lutein + zeaxanthin.  Β-cryptoxanthin levels were also lower in infants in this study (9.3 
µg/L vs. 12 µg/L).  The other carotenoid cord blood levels, total lycopene (21.8 µg/L vs. 12 
µg/L), α-carotene (5.4 µg/L vs. 2 µg/L), and β-carotene (18.3 µg/L vs. 7.9 µg/L), were all higher 
in the infants in the present study.2  More variability in carotenoid levels was found when 
compared to a study by Sommerburg et al.  Mean lycopene (21.8 µg/L vs. 16 µg/L), α-carotene 
(5.4 µg/L vs. 5 µg/L), and β-carotene (18.3 µg/L vs. 24 µg/L) in this study were found to differ 
when compared to median levels in infants in Germany.5   
In our sample of mothers, all carotenoid levels measured were lower than those found in 
a study by Weber et al. in Germany.  Carotenoids in our study compared to the results of Weber 
et al. for mothers at birth, respectively, are 0.287 µmol/L vs. 0.639 µmol/L for lutein + 
zeaxanthin, 0.133 µmol/L vs. 0.399 µmol/L for β-cryptoxanthin, 0.829 µmol/L vs. 1.08 µmol/L 
for total lycopene, 0.090 µmol/L vs. 0.323 µmol/L for α-carotene, and 0.374 µmol/L vs. 0.755 
µmol/L for total β-carotene.18  However, our results compared to mothers in Ireland were mixed.  
Our study demonstrated higher levels of total lycopene (0.829 µmol/L vs. 0.40 µmol/L), total β-
carotene (0.374 µmol/L vs. 0.23 µmol/L) and α-carotene (0.090 µmol/L vs. 0.05 µmol/L) in 
mothers and lower levels of lutein + zeaxanthin (0.287 µmol/L vs. 0.46 µmol/L).  β-cryptoxanthin 
concentrations, interestingly, were very similar (0.133 µmol/L vs. 0.14 µmol/L).33 
The NHANES III serum carotenoids levels of general adult women, although not 
exclusive to pregnant women, aligned fairly closely to the results of this study for β-carotene 
(200.9 µg/L vs. 150-217 µg/L in NHANES III), α-carotene (48.4 µg/L vs. 34.4-53.7 µg/L in 
NHANES III), β-cryptoxanthin (73.5 µg/L vs. 73.3-88.4 µg/L in NHANES III), and lutein + 
zeaxanthin (163.3 µg/L vs. 186-214 µg/L in NHANES III).  The one exception was the mothers 
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in this study had higher lycopene levels at 444.9 µg/L compared to 229-248 µg/L in adult females 
in the samples collected in NHANES III.15 
Due to limited previous research on serum carotenoid levels in pregnant women and 
infants at birth and no established reference values, the adequacy or deficiency in our sample was 
difficult to determine. 
Relationship between Serum Vitamin A Levels of Mothers and Infants:  
Not only were maternal retinol levels significantly positively correlated with cord blood 
levels, all measured carotenoids were as well.  These significant findings provide further evidence 
of the placental transfer of vitamin A compounds in utero.  Fernandes et al. also found a 
significant correlation with serum retinol levels (r=0.27, p=0.04),25 although Weber et al. 
(r=0.099, p=0.228)18 and Kiely et al. did not (r=0.19).33  Previous research has also shown 
positive correlations of maternal and infant lutein (r=0.368, p=<0.001), α-carotene (r=0.668, 
p=<0.001), and β-carotene (r=0.832, p=<0.001).18  These results support the importance of 
improving maternal levels throughout pregnancy in order to benefit the developing fetus. 
 
MATERNAL VITAMIN A INTAKE 
Because mothers influence the retinol and carotenoid concentrations of their infant via 
placental transfer, it is important to determine which dietary vitamin A compounds influence 
serum concentrations.  This is the first study to date to our knowledge that thoroughly evaluates 
the diets of mothers throughout pregnancy using a detailed FFQ and evaluates how dietary intake 
of specific vitamin A compounds influences serum levels of mothers and infants.  The median 
vitamin A intake measured in RAE in our sample of mothers was 3.5 times the EAR and 2.5 
times the RDA for pregnant women.  It was also 2.5 times higher than the NHANES III intake 
reports for pregnant women (1937.4 µg vs. 757 µg).10  Median RAE intake in our study was also 
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well above the intake in mothers in Israel (1937.4 µg vs. 237.1 µg).38  Given that maternal 
vitamin A intake greatly exceeded the DRIs, it could be expected to translate into adequate serum 
levels.  However, deficiency was still prevalent in our study population.  Also RAE intake did not 
correlate with serum retinol levels in both mothers and infants in our sample.  The current DRIs 
take into account a combination of all vitamin A compounds by converting to a common unit of 
RAE, but this may not be a sufficient measure to assume adequate intake and thus adequate 
serum levels.  
In comparison to the NHANES III data, median intake of β-cryptoxanthin (130.7 µg vs. 
159 µg), lycopene (3637.2 µg vs. 8713 µg), and α-carotene (267.8 µg vs. 376 µg) were all lower 
in this study.  Intake of lutein + zeaxanthin (2060.2 µg vs. 1455 µg) and β-carotene (4336.6 µg vs. 
1531 µg) were the only carotenoids consumed in higher amounts in this study population than the 
pregnant women evaluated in NHANES III.10  There may be specific dietary vitamin A 
compounds that are important in optimizing vitamin A serum status.  This has not been 
previously explored.  Interestingly, maternal dietary intake of lutein + zeaxanthin did not 
statistically correlate with maternal serum lutein + zeaxanthin, but it did positively correlate with 
serum α-carotene and β-carotene.  Other correlations observed included maternal intake of α-
carotene being significantly positively correlated with maternal serum α-carotene as well as being 
positively correlated with serum β-carotene, although not statistically significant (p=0.058).  β-
carotene was also significantly positively correlated with both serum β-carotene and α-carotene.  
None of the other dietary intake measures directly correlated with its corresponding serum 
measure.  These findings suggest that β- and α-carotenes influence serum levels similarly and 
could be obtained in the diet from the same food source.  This also brings into question how the 
metabolism of each vitamin A compound may affect the others when consumed together.  With 
our earlier results that all serum levels of the vitamin A compounds correlated positively in cord 
blood, it can be assumed that enhancing the serum vitamin A status in mothers will enhance the 
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infant’s vitamin A status at birth.  Due to only obtaining dietary intake information on 59% of our 
subjects, dietary vitamin A intake in mothers may not be representative of the study population.  
Further evaluations with larger samples need to be completed before stronger conclusions can be 
drawn.   
Not only is maternal dietary intake important throughout pregnancy, it continues to be 
crucial after birth if infants are breast fed.  Low dietary vitamin A intake and low serum 
concentrations in mothers may lead to the development of VAD after birth or contribute to a 
failure to form adequate vitamin A liver stores in later infancy and childhood. 
 
IMPROVING VITAMIN A STATUS 
The method to increase vitamin A status after birth is controversial.  Various forms of 
supplementation given to mothers and infants have been assessed.  Pregnant women are advised 
to avoid supplementing their diet with >10,000 IU of preformed vitamin A.  These high dose 
supplements have been associated with malformation of the fetus.21  Also, supplementation to 
mothers during pregnancy has not shown beneficial effects on neonatal birth weight, length, and 
head circumference.20  Given the risk of negative consequences of vitamin A toxicity from 
supplementation, WHO does not recommend vitamin A supplementation during pregnancy to 
prevent maternal and infant morbidity and mortality.  However, in areas where VAD is a public 
health issue, WHO recommends supplementing pregnant women with vitamin A to help prevent 
gestational night blindness.  In addition, WHO does not recommend supplementation for nursing 
mothers, but encourages proper nutrition through a balanced diet.39  Improving breast milk 
concentrations may help increase vitamin A intake for infants who are breast fed.  Retinoids and 
carotenoids are not homeostatically regulated in breast milk, thus higher dietary intake can 
contribute to a higher composition in breast milk.45  Haftel et al. showed 130% and 200% 
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increases in lycopene and β-carotene breast milk content, respectively, when mothers 
supplemented their diet with carrot puree or mashed tomatoes.9   
Infant intake through formula may also be an area to target to improve infant vitamin A 
status.  Sommerburg et al. evaluated breast milk and formula content and found that four major 
carotenoids (α-carotene, β-carotene, lycopene, and cryptoxanthin) were detected in breast milk 
samples, but formulas were lacking these vitamin A compounds.  Of the eight formulas tested, 
50% did not contain any of the carotenoids, 50% contained β-carotene, and 38% contained β-
cryptoxanthin.5  Rubin et al. determined that infants who received supplemented formula with 
lutein + zeaxanthin, lycopene, and β-carotene had considerably higher corresponding plasma 
levels.46  Adding vitamin A compounds to formula may be a feasible and safe way to improve 
vitamin A status in infants. If a more aggressive treatment is needed for severe VAD, it may be 
appropriate to administer higher doses of vitamin A.  Supplementing infants with 5000 IU 
vitamin A intramuscularly, three times per week for 28 days, has also been shown to improve 
vitamin A levels and decrease the risk of chronic lung disease in very low birth weight 
infants.3  Vitamin A supplementation is still debatable due to inconclusive research and may need 
to be considered on an individual basis.  Supplementation through carotenoids may be more 
appropriate compared to supplementation of preformed vitamin A, but would need to be 
evaluated further before general recommendations could be made. 
 
LIMITATIONS 
The limitations of this study should be considered.  A larger sample size would have been 
beneficial to establish more solid findings that could be generalized to a larger population.  In 
addition to the small sample of 34 mother-infant pairs enrolled, serum samples from three 
mothers and cord blood samples from two infants were not obtained.  Also, this study looked at 
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subjects in the NICU, who are often under higher levels of stress due to an increase in health 
complications.  These results may not be consistent with healthy mother-infant pairs at birth. 
The FFQs were also completed and analyzed in only 20 of the mothers.  Almost half of 
the mothers did not complete a FFQ, making it difficult to draw solid conclusions related to the 
intake of vitamin A compounds.  As with other intake assessment forms, self-reporting can lead 
to both under or overestimations of intake.  The FFQ also asked questions regarding the 
frequency of intake of specific foods on average over the past year.  With many vitamin A-
containing foods being seasonal, it may have been difficult for subjects to accurately fill out the 
FFQ.  The FFQ used, though, did provide a thorough intake assessment and has been used in 
many other adult populations. 
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CHAPTER 6: CONCLUSION 
 This is one of the first studies to not only evaluate vitamin A status from retinol levels, 
but more importantly, assess the carotenoid status in mothers and infants at birth.  Previously, 
limited data has been available regarding the current status of the various vitamin A compounds 
in the United States.  This prospective study determined VAD is a significant problem in this 
population of infants and is influenced by the maternal vitamin A status.  In addition, maternal 
intake may influence the serum levels of mothers and infants, although further research needs to 
be completed to determine the influence of specific carotenoid intake on serum concentrations of 
vitamin A compounds.  Additional research evaluating vitamin A intake after birth including 
dietary intake, supplementation of preformed vitamin A vs. carotenoids, or a combination would 
provide an insight into how VAD can be prevented or corrected in early infancy and childhood.  
With a larger sample in the future, comparisons could be made between different gestational ages 
and birth weights, which may help target high risk populations. 
Evaluating correlations of retinol and carotenoid concentrations between mothers and 
infants provides important information to help determine appropriate strategies and specific 
vitamin A components to target to improve vitamin A status in both parties.  By increasing 
awareness of the significant VAD present in NICU babies in the Midwest, appropriate 
assessments and interventions can be implemented to provide optimal care and improve health 
outcomes. 
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